Mid-Day Breakouts Report - Monday, November 28th, 2022

<<<Previous Mid Day Report	Next Mid Day Report >>>
<<<Previous After Market Report	Next After Market Report >>>

You are not logged in.
This means you CAN ONLY VIEW reports that were published prior to Sunday, October 20, 2024.
You MUST UPGRADE YOUR MEMBERSHIP if you want to see any current reports.

MIDDAY BREAKOUTS REPORT - MONDAY, NOVEMBER 28TH, 2022
Previous Mid Day Report Next Mid Day Report >>>

DOW 34089.63 -257.4 (-0.75%) | NASDAQ 11148.63 -77.72 (-0.69%) | S&P 500 3994.86 -31.26 (-0.78%)

Time of Screening : 11/28/2022 12:16:47 PM Report Released : 11/28/2022 12:45:51 PM
Price is: Above 52W High and Less Than 52W High but within 15% of the 52 Week High
Volume Is: At least 57.5% of 50 Day Average at the time of the screening.
More details about this report...

To View Current Notes and Data on currently Featured Stocks go to the latest
Featured Stocks Page

Symbol/Exchange Company Name Industry Group	PRICE	CHANGE (%Change)	Day High	Volume (% DAV) (50 DAV)	52 Wk Hi % From Hi	Date Featured	Price Featured	Pivot Point
Symbol/Exchange Company Name Industry Group	PRICE	CHANGE (%Change)	Day High	Volume (% DAV) (50 DAV)	52 Wk Hi % From Hi	Date Featured	Price Featured	Max Buy
CPRX - NASDAQ Catalyst Pharma Partners	$17.16	+0.19 1.12%	$18.39	1,878,008 77.48% of 50 DAV 50 DAV is 2,424,000	$17.76 -3.38%	11/22/2022	$17.38	PP = $16.66 MB = $17.49
Most Recent Note - 11/28/2022 12:25:30 PM Y - Perched at its all-time high today. Rallied from a 9-week cup-with-handle base with a big gain backed above average volume noted. Reported Sep '22 quarterly earnings +86% on +59% sales revenues versus the year ago period. Disciplined investors avoid chasing stocks that are extended more than +5% above prior highs or the "max buy" level. >>> The latest Featured Stock Update with an annotated graph appeared on 11/22/2022. Click here.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M

Symbol - Exchange - Industry Group Company Name	Last	Chg	Day High	52 WK Hi	% From Hi	Volume % DAV	DAV
BMRN - NASDAQ - DRUGS - Drug Manufacturers - Other Biomarin Pharmaceutical	$99.40	+2.48 2.56%	$100.30	$99.74	-0.34%	827,637 60.32%	1,372,000
Most Recent Note for BMRN - 11/28/2022 12:18:25 PM Gapped up 11/23/22 and rallied to a new 52-week high with a considerable volume-driven gain. Reported strong Sep '22 quarterly earnings +150% on +24% sales revenues versus the year ago period. Prior quarterly comparisons were sub par and fundamentals are not a match with the fact-based investment system's guidelines (C and A criteria). It was dropped from the Featured Stocks list on 8/19/20.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
CECO - NASDAQ - Pollution Control Ceco Environmental	$12.06	-0.10 -0.78%	$12.44	$12.54	-3.87%	174,170 66.48%	262,000
Most Recent Note for CECO - 11/28/2022 12:21:43 PM Perched at its 52-week high today after 4 consecutive gains backed by light volume. Recent quarterly comparisons through Sep '22 showed strong sales revenues and earnings increases of more than +25% above the year ago periods (C criteria). Annual earnings (A criteria) history has been up and down.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
FUTU - NASDAQ - Finance-Invest Bnk/Bkrs Futu Holdings Cl A Ads	$53.42	+0.71 1.35%	$55.12	$57.76	-7.51%	1,296,393 58.74%	2,207,000
Most Recent Note for FUTU - 11/28/2022 12:25:58 PM Reported Sep '22 quarterly earnings +35% on +11% sales revenues versus the ear ago period, its 2nd strong quarterly comparison (C criteria) above the +25% minimum. Prior history is sub par. China-based Financial firm completed a new Public Offering on 8/18/20. Completed its $12 IPO on 3/08/19.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
GMAB - NASDAQ - Medical-Biomed/Biotech Genmab A/S Ads	$45.58	+1.26 2.84%	$45.72	$44.56	2.29%	380,001 61.59%	617,000
Most Recent Note for GMAB - 11/28/2022 12:26:28 PM Steadily rebounding toward its all-time high. Prior mid-day reports noted - "Reported Sep '22 quarterly earnings +148% on +50% sales revenues versus the year ago period. Prior quarterly comparisons were erratic and its annual earnings (A criteria) had a downturn in FY'21. Limited history remains a concern and has not been a good match with the fundamental guidelines of the fact-based investment system."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
HGBL - NASDAQ - Finance-Investment Mgmt Heritage Global Inc	$2.45	+0.01 0.41%	$2.45	$2.68	-8.58%	38,080 73.23%	52,000
Most Recent Note for HGBL - 11/28/2022 12:26:57 PM Consolidating near its 52-week high after a noted spurt of volume-driven gains. Reported Sep '22 quarterly earnings +500% on +111% sales revenues versus the year ago period, its 2nd strong quarterly comparison. Prior quarterly and annual earnings (C and A criteria) history has not been a match with the fact-based investment system's guidelines.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
IBCP - NASDAQ - BANKING - Regional - Midwest Banks Independent Bank Corp Mi	$24.26	-0.38 -1.52%	$24.61	$26.00	-6.71%	61,019 92.45%	66,000
Most Recent Note for IBCP - 11/28/2022 12:27:40 PM Hovering in a tight range perched within striking distance of its 52-week high. Reported earnings +11% on +11% sales revenues for the Sep '22 quarter versus the year ago period, and prior quarterly earnings comparisons were below the +25% minimum guideline (C criteria). Annual earnings were flat in FY '21 after years of strong and steady growth.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
IBEX - NASDAQ - Computer- Tech Services Ibex Ltd	$25.95	+0.49 1.92%	$26.11	$26.93	-3.64%	32,559 70.78%	46,000
Most Recent Note for IBEX - 11/28/2022 12:28:11 PM Perched at its all-time high following a noted spurt of volume-driven gains. No resistance remains due to overhead supply. Bermuda-based technology firm reported Sep '22 quarterly earnings +580% on +18% sales revenues versus the year ago period. Reported strong earnings growth in the Mar and Jun '22 quarters versus the year ago periods. Annual earnings history has been strong since its $19 IPO on 8/07/20.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
LIN - NYSE - Chemicals-Specialty Linde Plc	$341.98	-2.44 -0.71%	$344.93	$352.18	-2.90%	1,269,194 67.51%	1,880,000
Most Recent Note for LIN - 11/28/2022 12:31:53 PM This UK-based Chemicals - Specialty firm is perched within striking distance of its all-time high after 9 consecutive weekly gains. Through Sep '22 its 4 latest quarterly earnings comparisons versus the year ago periods were below the +25% minimum guideline (C criteria). Its annual earnings (A criteria) history has been steady.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
LYTS - NASDAQ - Bldg-Constr Prds/Misc L S I Industries Inc	$11.39	+0.35 3.17%	$11.44	$11.44	-0.44%	83,412 85.11%	98,000
Most Recent Note for LYTS - 11/28/2022 12:34:14 PM It has not formed a sound looking base. Rallied abruptly from a low of $6.55 on 10/25/22 and to new highs above its 2021 high with recent volume-driven gains. Recent quarterly comparisons through Sep '22 versus the year ago period showed strong sales revenues and earnings increases versus the year ago periods. Annual earnings history has been strong after a downturn in FY '19.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
MLI - NYSE - MANUFACTURING - Metal Fabrication Mueller Industries Inc	$68.89	-0.96 -1.38%	$69.40	$70.43	-2.19%	218,390 68.89%	317,000
Most Recent Note for MLI - 11/28/2022 12:35:25 PM Pulling back today after wedging to a new 52-week high with gains lacking volume. Reported Sep '22 quarterly earnings -9% on -4% sales revenues versus the year ago period. Prior quarterly earnings comparisons were strong and steady above the +25% minimum guideline (C criteria). Annual earnings history had a slight downturn in FY '19, not a great match with the fact-based investment system's guidelines.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
MNSB - NASDAQ - Banks-Southeast Mainstreet Bancshares	$28.87	+0.19 0.65%	$29.03	$30.98	-6.83%	12,925 64.63%	20,000
Most Recent Note for MNSB - 11/28/2022 12:37:41 PM Perched near its all-time high following volume-driven gains. Reported strong Sep '22 quarterly results but prior fundamentals are not a match with the fact-based investment system's fundamental guidelines (C and A criteria).
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
TIPT - NASDAQ - Financial Svcs-Specialty Tiptree Financial Cl A	$13.66	+0.11 0.77%	$13.75	$15.21	-10.22%	52,399 95.27%	55,000
Most Recent Note for TIPT - 11/28/2022 12:38:06 PM Fundamental concerns remain.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
UNVR - NYSE - Chemicals-Specialty Univar Solutions Inc	$32.43	+1.43 4.60%	$33.58	$34.00	-4.63%	3,748,413 259.77%	1,443,000
Most Recent Note for UNVR - 11/28/2022 12:39:10 PM Gapped today challenging its 52-week high with a considerable volume-driven gain. Quarterly comparisons through Sep '22 showed greatly improved sales revenues and earnings versus the year ago periods. Its annual earnings (A criteria) history had a downturn in FY '19 and '20, not a match with the winning models of the fact-based investment system.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
VOC - NYSE - Oil&Gas-Royalty Trust V O C Energy Trust	$9.36	-0.51 -5.17%	$9.83	$10.06	-6.96%	109,495 67.59%	162,000
Most Recent Note for VOC - 11/28/2022 12:41:14 PM Pulling back today after rallying near its 52-week high with a big gain when the 11/25/22 mid-day report noted - "Reported Sep '22 quarterly earnings +138% on +143% sales revenues versus the year ago period. Recent quarterly comparisons showed great percentage earnings increases over the year ago periods. Quarterly sales revenues totals have been in the $2-7 million range, rather minuscule relative to most publicly traded companies worthy of serious consideration under the fact-based investment system."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M

THESE ARE NOT BUY RECOMMENDATIONS! Comments contained in the body of this report are technical opinions only. The material herein has been obtained from sources believed to be reliable and accurate, however, its accuracy and completeness cannot be guaranteed. We are not an investment advisor, hence it does not endorse or recommend any securities or other investments. Any recommendation contained in this report may not be suitable for all investors and it is not to be deemed an offer or solicitation on our part with respect to the purchase or sale of any securities. All trademarks, service marks and trade names appearing in this report are the property of their respective owners, and are likewise used for identification purposes only.

This report is a service available only to active Paid Premium Members. You may opt-out of receiving report notifications at any time. Questions or comments may be submitted by writing to FactBasedInvesting.com c/o Premium Member Services 665 S.E. 10 Street, Suite 201 Deerfield Beach, FL 33441-5634 or by calling 954-785-1121.

We appreciate any feedback members may wish to send via the inquiry form here.